These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 367495)

  • 1. Plasma lipoproteins in renal transplant patients.
    Evans DB; Ghosh P
    Br Med J; 1979 Jan; 1(6155):21. PubMed ID: 367495
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum lipoproteins in renal transplant patients: the effect of cyclosporine on lipoprotein(a).
    Süleymanlar G; Ozben T; Sapan M; Yìlmaz H; Yakupoglu G; Karpuzoglu T
    Transplant Proc; 1994 Oct; 26(5):2637-8. PubMed ID: 7940822
    [No Abstract]   [Full Text] [Related]  

  • 3. Abnormal lipid and lipoprotein profiles following renal transplantation.
    Moore R; Thomas D; Morgan E; Wheeler D; Griffin P; Salaman J; Rees A
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1060-1. PubMed ID: 8442042
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of chronic uremia, hemodialysis, and renal transplantation on plasma lipids and lipoproteins in man.
    Bagdade J; Casaretto A; Albers J
    J Lab Clin Med; 1976 Jan; 87(1):38-48. PubMed ID: 173766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disturbances of lipid metabolism following renal transplantation (author's transl)].
    Zazgornik J; Bayer PM; Schmidt P; Pils P; Bratusch-Marrain P; Kopsa H
    Wien Klin Wochenschr; 1975 Oct; 87(19):648-50. PubMed ID: 775798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients.
    Kimak E; Ksiazek A; Baranowicz-Gaszczyk I; Solski J
    Ren Fail; 2007; 29(6):705-12. PubMed ID: 17763166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein profile in dialysis and transplant patients.
    Lau YK; Woo KT; Lim CH
    Singapore Med J; 1985 Apr; 26(2):193-7. PubMed ID: 3898396
    [No Abstract]   [Full Text] [Related]  

  • 8. Dyslipidemia in renal transplantation: a 3-year follow-up.
    Segoloni GP; Triolo G; Cassader M; Turello E; Ruiu G; Messina M; Pagano GF; Vercellone A
    Transplant Proc; 1993 Jun; 25(3):2178-9. PubMed ID: 8516860
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipid disorders in renal transplant recipients.
    Ponticelli C; Barbi GL; Cantaluppi A; De Vecchi A; Annoni G; Donati C; Cecchettin M
    Nephron; 1978; 20(4):189-95. PubMed ID: 345139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid metabolic abnormalities after renal transplantation under cyclosporine and prednisone immunosuppression.
    Castelao AM; Barberá MJ; Blanco A; Fiol C; Griñó JM; Bover J; GilVernet S; Andrés E; Serón D; Castiñeiras MJ
    Transplant Proc; 1992 Feb; 24(1):96-8. PubMed ID: 1539356
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperlipidaemia in renal transplant patients.
    Goldberg RB; Judelman JJ; Mindel A; Meyers AM; Salant DJ; Myburgh JA; Rabkin R; Joffe BI; Seftel HC
    S Afr Med J; 1976 Jul; 50(33):1291-4. PubMed ID: 785623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperlipidemia in stable renal transplant recipients.
    Ong-Ajyooth L; Sirisalee K; Shayakul C; Vareesangthip K; Vasuvattakul S; Chirawong P; Vanichakarn S; Nimmannit S; Ong-Ajyooth S; Nilwarangkur S
    Transplant Proc; 1994 Aug; 26(4):2062-4. PubMed ID: 8066670
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperlipidemia following renal transplantation.
    Ibels LS; Alfrey AC; Subryan V; Weil R
    Trans Am Soc Artif Intern Organs; 1976; 22():46-53. PubMed ID: 781985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of lipoproteins on cyclosporine pharmacokinetics and biological activity in transplant patients.
    Awni WM; Heim-Duthoy K; Kasiske BL
    Transplant Proc; 1990 Jun; 22(3):1193-6. PubMed ID: 2349681
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased lipoproteins and fibrinogen in chronic renal allograft dysfunction.
    Fernandez-Miranda C; Morales JM; Porres A; Gomez-Gerique J; Guijarro C; Aranda JL; Andres A; Rodicio JL; Del Palacio A
    Am J Nephrol; 1997; 17(5):445-9. PubMed ID: 9382164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of changes in lipid profiles in cyclosporine-treated renal transplant patients.
    Markell MS; Brown CD; Butt KM; Friedman EA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1497-9. PubMed ID: 2652482
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the nature and causes of hyperlipidaemia in uraemia, maintenance dialysis and renal transplantation.
    Ibels LS; Simons LA; King JO; Williams PF; Neale FC; Stewart JH
    Q J Med; 1975 Oct; 44(176):601-14. PubMed ID: 1105647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of immunosuppressive therapy on lipoprotein(a) and other lipoproteins following renal transplantation.
    Brown JH; Murphy BG; Douglas AF; Short CD; Bhatnagar D; Mackness MI; Hunt LP; Doherty CC; Durrington PN
    Nephron; 1997; 75(3):277-82. PubMed ID: 9069448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lipids on chronic uraemic and transplantation patients.
    Viikari J; Forsström J
    Ann Clin Res; 1979 Jun; 11(3):113-7. PubMed ID: 227315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein abnormalities in renal transplant recipients with chronic vascular rejection.
    Dimény E; Fellström B; Larsson E; Tufveson G; Lithell H
    Transplant Proc; 1992 Feb; 24(1):366. PubMed ID: 1539319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.